Interhospital Variability in Programmes to Prevent Axillary Lymphadenectomy Sequels in Breast Cancer Patients.
NCT ID: NCT03300349
Last Updated: 2018-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
276 participants
OBSERVATIONAL
2017-09-27
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preoperative and Intraoperative Quantification of Axillary Tumoral Load
NCT02197949
ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer
NCT04889924
Surgical Breast Resection With or Without Axillary Lymph Node Excision in Treating Women With Breast Cancer
NCT00210236
Mastectomy in Ambulatory Breast Surgery
NCT03003169
Medico-economic Study of Three Strategies of Sentinel Lymph Node Analysis in Operable Breast Cancer
NCT02056886
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
axillary lymphadenectomy sequels
Patients who have suffered from axillary lymphadenectomy due to breast cancer between 2014 and 2016 and who have developed breast cancer-related lymphedema and/or shoulder disability who fulfill or not a preventive programme
Fulfillment of a preventive programme
Information about risk factors for breast cancer-related lymphedema and home-based exercise programme for shoulder
No fulfillment of a preventive programme
No fulfillment of the preventive programme: Information about risk factors for breast cancer-related lymphedema and home-based exercise programme for shoulder
No axillary lymphadenectomy sequels
Patients who have suffered from axillary lymphadenectomy due to breast cancer between 2014 and 2016 and who have not develped breast cancer-related lymphedema and/or shoulder disability who fulfill or not a preventive programme.
Fulfillment of a preventive programme
Information about risk factors for breast cancer-related lymphedema and home-based exercise programme for shoulder
No fulfillment of a preventive programme
No fulfillment of the preventive programme: Information about risk factors for breast cancer-related lymphedema and home-based exercise programme for shoulder
Fulfillment of a preventive programme
Patients who fulfil a preventive programme for axillary lymphadenectomy sequels
No interventions assigned to this group
No fulfillment of a preventive programme
Patients who do not fulfil a preventive programme for axillary lymphadenectomy sequels
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fulfillment of a preventive programme
Information about risk factors for breast cancer-related lymphedema and home-based exercise programme for shoulder
No fulfillment of a preventive programme
No fulfillment of the preventive programme: Information about risk factors for breast cancer-related lymphedema and home-based exercise programme for shoulder
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Cognitive impairment or intellectual disability that would prevent understanding the instructions of the study, as well as the purpose of the same.
* Serious condition.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Universitario 12 de Octubre
OTHER
University of Castilla-La Mancha
OTHER
Puerta de Hierro University Hospital
OTHER
Complejo Hospitalario Universitario de Cartagena
UNKNOWN
Violeta Pajero Otero
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Violeta Pajero Otero
Physiotherapist at the Mammary Pathology Unit
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Violeta Pajero Otero, MRes
Role: PRINCIPAL_INVESTIGATOR
Hospital Universitario 12 de Octubre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitario Puerta de Hierro
Majadahonda, Madrid, Spain
Complejo Hospitalario Universitario de Cartagena
Cartagena, Murcia, Spain
Hospital Universitario Ramón y Cajal
Madrid, , Spain
Hospital Universitario 12 de Octubre
Madrid, , Spain
Castilla-La Mancha University
Toledo, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
InveCuidRh001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.